The inventions relates to a transurethral catheter device for bleeding control in pelvic fractures. The catheter device comprises an expandable body assembly with at least one expandable body. The expandable body assembly comprises a proximal portion, a center portion and a distal portion. The expandable body assembly is configured to be expanded from a collapsed state to an expanded state by expanding the at least one expandable body. The expandable body assembly is further configured to be inserted into the urinary bladder of a patient via the urethra in the collapsed state. In the expanded state, the proximal portion has a length l.sub.1 and a width w.sub.1, the center portion a length l.sub.2 and a width w.sub.2, the distal portion a length l.sub.3 and a width w.sub.3, and the expandable body assembly a total length l. A displacement volume V of the expandable body assembly in the expanded state is larger than 0.5 liters. The width w.sub.2 is smaller than 50% of the width w.sub.3. The width w.sub.1 is larger than a width {tilde over (w)}.sub.1 of the proximal portion in the collapsed state and the width w.sub.3 is larger than a width {tilde over (w)}.sub.3 of the distal portion in the collapsed state. The length l.sub.1 is smaller than 25% of the total length l. This allows for arranging the expandable body assembly in the expanded state in the urinary bladder such that the proximal portion is adjacent to the internal urethral orifice of the urinary bladder and the center portion is adjacent to the ureter orifices of the urinary bladder, but not in contact with the ureter orifices.

A temporary low profile intraluminal catheter for infusing agents into, or extracting fluids from, a bodily lumen comprising securement means, wherein said securement means allows said catheter to be placed with minimal intrusion into said bodily lumen is disclosed. With such design affording a more efficient, verifiable placement of said catheter with less complication due to infection and biofilm related issues, among other types of complications.

A ureteral stent is provided. The stent may include a first section having a first wall defining a first luminal section. The stent may further include a second section having a second wall defining a second luminal section. The second section can be enabled to substantially close at times external pressure is applied to the stent.

In one example, a system includes an elongated body defining a lumen where the elongated body includes a proximal portion and a distal portion. An anchoring member may be positioned on the proximal portion of the elongated body. The system further includes a sensor located on the elongated body where the sensor may be configured to sense at least one flow parameter of a fluid within the lumen. In some examples, the system includes processing circuitry configured to determine at least one of a density parameter or a temperature parameter of the fluid in the lumen based on the sensed at least one flow parameter of the fluid.

The invention provides a device for treating urinary incontinence having a fillable expandable balloon made of a flexible material. The wall of the balloon has at least one recess and a valve. A central core located in the lumen of the balloon encloses a central channel having one or more openings and one or more magnetable elements there being.

Described are means for the direct and continuous connection of a catheter to the lumen of any tubular anatomical structure, or ductus, without medically significant leakage. A port implanted at the body surface with piping to a periductal collar allows drug or radionuclide delivery that bypasses the upstream lumen. The port allows injection, infusion, aspiration, or attachment of an automatic ambulatory pump. A superparamagnetic nanoparticle carrier-bound drug, for example, can be introduced into the lumen to pass downstream until the particles, with or without the drug still bound, are drawn into the lumen wall by a magnetized jacket surrounding the ductus. Such constitutes a method of drug targeting whereby a segment of a vessel or the territory supplied by a branch of that segment can be circumscribed for exposure to the drug. A jacket with side-entry connector positioned in surrounding relation to a lesion requiring treatment can itself be magnetized.

Negative pressure therapy systems are provided for increasing urine production, the negative pressure therapy system including: (a) a pump assembly, the pump assembly including: (i) a pump configured to provide negative pressure to a kidney, and (ii) a controller configured to regulate the negative pressure provided by the pump within a pressure range that facilitates increased urine production from the kidney.

A balloon catheter for treating, preventing, or reducing the recurrence of a stricture and/or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen; the ballon catheter comprising: An elongated balloon; a coating layer overlying an exterior surface of the balloon wherein the coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent; and a length-control mechanism (600) which stretches and elongates the balloon during deflation, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment.

A catheter configured to be deployed in a urinary tract of a patient includes a proximal portion configured to pass through a percutaneous opening and a distal portion including a retention portion. The retention portion is configured to be deployed in a kidney, renal pelvis, and/or bladder of the patient. The retention portion includes one or more protected drainage holes, ports or perforations and is configured, when deployed, to establish an outer periphery or protective surface area that inhibits mucosal tissue from occluding the one or more protected drainage holes, ports, or perforations upon application of negative pressure through the catheter.

An external catheter assembly for facilitating non-invasive catheterization includes a male catheter that is wrappable around a penis to capture urine from the penis. A first tube is fluidly coupled to the male catheter to receive the urine from the penis. A first collection bag is fluidly coupled to the first tube to capture the urine from the penis. A female catheter is positionable within the labia minora of a female patient to capture urine from the female patient. A second tube is fluidly coupled to the female catheter to receive the urine from the female patient. A second collection bag is fluidly coupled to the second tube to capture the urine from the female patient.